Medtech | Jotup

Olympus Corporation of the Americas' Julien Sauvagnargues Steps into CEO Role

Retrieved on:

Wednesday, March 27, 2024

Grifols, Nachos, Olympus Corporation, AdvaMed, OCA, CSO, Medtech, Corporation, Management

CENTER VALLEY, Pa., March 27, 2024 /PRNewswire/ -- Olympus, a leading global MedTech company providing innovative solutions for medical and surgical procedures, announced today the appointment of Julien Sauvagnargues to the role of President and Chief Executive Officer (CEO), Olympus Corporation of the Americas (OCA), reporting to Olympus Chief Strategy Officer (CSO), Gabriela Kaynor, effective April 1, 2024.

Key Points:

This new step in Mr. Sauvagnargues' career at Olympus, which began in 2006, builds upon his tenure as OCA President since 2020.
Mr. Glavin came to Olympus in 2016 in a consultant role and became the OCA Chief Compliance Officer that same year.
These leadership changes are in part due to the departure from Olympus of Nacho Abia, former OCA CEO and global CSO.
"We cannot be grateful enough for Nacho's 23-year tenure with this company," said Stefan Kaufmann, CEO, Olympus Corporation.

United States Robotics Integration for the Manufacturing Research Report 2024-2029: Material Handling and Motion Control, Platforms, Systems, and Architecture, Transition to Industry 5.0

Retrieved on:

Wednesday, March 27, 2024

The integration of robotics is reshaping various sectors, including manufacturing, healthcare, and service industries, by enhancing efficiency, productivity, and safety.

Key Points:

The integration of robotics is reshaping various sectors, including manufacturing, healthcare, and service industries, by enhancing efficiency, productivity, and safety.
For instance, the Advanced Robotics for Manufacturing (ARM) Institute reflects a concerted effort to fortify the country's global leadership in this domain.
Moreover, collaboration between universities and industry is pivotal in pushing the boundaries of robotics technology, ensuring a steady flow of skilled labor, and addressing the challenges of integration.
Robotics integration is pivotal in automating repetitive and hazardous tasks, leading to enhanced efficiency and reduced downtime.

World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain

Retrieved on:

Tuesday, March 26, 2024

Diagnosis, Biopsy, Sentinel lymph node, Radiation, Prostate cancer, Patient, ASX, SLN, Prostate, Bladder cancer, Hospital, TLX, Lymph node, Health technology, Medtech, AA, Medical imaging

SENSEI® is smaller than an AA battery and designed specifically for robotic-assisted and minimally invasive surgery.

Key Points:

SENSEI® is smaller than an AA battery and designed specifically for robotic-assisted and minimally invasive surgery.
The miniature size and proprietary features make the technology ideal for tight surgical spaces such as around the bladder.
Radio-guided surgery has historically been limited by the fact that gamma probes are generally only suitable for open surgery.
Nynke van den Berg, General Manager Medical Technologies (MedTech) at Telix added, "A first bladder cancer procedure with the SENSEI® drop-in gamma probe is a significant milestone for Telix and the Lightpoint team.

Activeloop Raises $11M Series A and Brings Its Database for AI to Fortune 500 Companies

Retrieved on:

Tuesday, March 26, 2024

Y Combinator, RAG, General partnership, Knowledge, AI, Database, Machine learning, Medtech

MOUNTAIN VIEW, Calif., March 26, 2024 /PRNewswire/ -- Activeloop, the leading Database for AI company, has raised $11 million in Series A funding from Streamlined Ventures, Y Combinator, Samsung Next, Alumni Ventures, and Dispersion Capital. The round brings Activeloop's total funding to about $20M.

Key Points:

Activeloop's Deep Lake seamlessly connects unstructured data—audio, video, images, text, and embeddings—to machine learning models, offering advanced storage and accurate retrieval for machine learning.
Activeloop's enterprise-ready database is popular among Fortune 500s in regulated sectors like biopharma, MedTech, legal, and automotive.
"For customers across industries, Activeloop feels like a magic box that helps teams organize their unstructured complex data and efficiently retrieve it for AI," said Davit Buniatyan, CEO of Activeloop.
"Enterprises seek AI to unlock value from complex data, which is only possible with systems like Activeloop's database for AI.

Greenlight Guru Wins USA Today Top Workplaces Award for 2024

Retrieved on:

Monday, March 25, 2024

Organization, Workplace, Heart, Medtech, Nursing

INDIANAPOLIS, March 25, 2024 /PRNewswire-PRWeb/ -- Greenlight Guru, the leading provider of cloud-based quality and clinical software for MedTech companies, proudly announces its achievement of the Top Workplaces USA 2024 Award. This prestigious recognition, awarded by Top Workplaces and based on comprehensive employee feedback, celebrates the company's dedication to fostering an outstanding workplace culture.

Key Points:

INDIANAPOLIS, March 25, 2024 /PRNewswire-PRWeb/ -- Greenlight Guru , the leading provider of cloud-based quality and clinical software for MedTech companies, proudly announces its achievement of the Top Workplaces USA 2024 Award.
Top Workplaces USA is an esteemed award program that honors organizations nationwide for their commitment to creating a positive work environment and prioritizing employee well-being.
This award reflects our commitment to creating an inclusive, supportive, and dynamic environment for our team ," said David DeRam, CEO of Greenlight Guru.
For more information about the Top Workplaces USA award and the companies recognized in 2024, please click here .

Revamp Medical Announces Appointment of Mike Favet as CEO

Retrieved on:

Thursday, March 21, 2024

Mechanical, Champaign–Urbana metropolitan area, Acute decompensated heart failure, Boston Scientific, Business administration, Patient, Revamp, University, Medtech, THT, FDA, Pharmaceutical industry

NETANYA, Israel, March 21, 2024 /PRNewswire/ -- Revamp Medical , Inc., a privately held clinical-stage medical technology company committed to developing solutions for Heart Failure congestion management, today announced the appointment of Mike Favet as Chief Executive Officer and member of the Board of Directors.

Key Points:

NETANYA, Israel, March 21, 2024 /PRNewswire/ -- Revamp Medical , Inc., a privately held clinical-stage medical technology company committed to developing solutions for Heart Failure congestion management, today announced the appointment of Mike Favet as Chief Executive Officer and member of the Board of Directors.
"Mike brings a distinguished track record of successful leadership in medtech and is ideally suited to build Revamp Medical from the solid foundation being demonstrated in the U.S.
Early Feasibility Study through the pivotal trial to support FDA approval" said Mike Berman, a Board Director of Revamp Medical.
"I am thrilled for the opportunity to join Revamp Medical at this significant juncture," said Mr. Favet.

SmartCardia Strengthens U.S. Board With Addition of Veteran Cardiac Device Leader Ken Nelson

Retrieved on:

Tuesday, March 19, 2024

American Heart Association, Harvard Medical School, Boston Scientific, Remote patient monitoring, Biotelemetry, Partnership, Roman, News, Acquisition, Digital health, Massachusetts General Hospital, Hospital, FDA, Boston, ECG, Mass, Medtech

SmartCardia CEO, Srini Murali, noted "Ken has deep experience in the cardiac monitoring industry and an impressive track record.

Key Points:

SmartCardia CEO, Srini Murali, noted "Ken has deep experience in the cardiac monitoring industry and an impressive track record.
He has worked with SmartCardia over the past year, and I am excited that he has now joined our team."
I am excited to be a part of this highly innovative company," noted Ken Nelson.
In addition, he serves as Chairman of the Board for CardiaCare, and is an active board member for HeartX, HeartBeam, Happitech, and a handful of other disruptive cardiac Digital Health and MedTech startups.

Virtuous Brings on Jeff Perkins as Chief Marketing Officer

Retrieved on:

Tuesday, March 19, 2024

CMO, CRM, Culture, Marketing, Software as a service, Growth, Sale, Medtech, Video game

PHOENIX, March 19, 2024 /PRNewswire/ -- Virtuous, the fastest-growing CRM for medium and large nonprofits, announced today the appointment of Jeff Perkins as its new Chief Marketing Officer (CMO). In this role, Perkins will help drive innovative marketing programs to build the brand and accelerate growth.

Key Points:

PHOENIX, March 19, 2024 /PRNewswire/ -- Virtuous, the fastest-growing CRM for medium and large nonprofits, announced today the appointment of Jeff Perkins as its new Chief Marketing Officer (CMO).
In this role, Perkins will help drive innovative marketing programs to build the brand and accelerate growth.
This hire comes at a pivotal time for Virtuous, following a successful year marked by significant business growth.
Perkins is an award-winning marketer who brings more than 25 years of executive leadership experience to Virtuous.

Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated

Retrieved on:

Tuesday, March 19, 2024

Growth, Surgeon, System, Patient, SAN, Hospital, Health care, Instrument, Moon, Nvidia, Sofinnova, Nursing, Artificial intelligence, Medtech

"Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated" - Kimberly Powell, Vice President of Healthcare at NVIDIA

Key Points:

"Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated" - Kimberly Powell, Vice President of Healthcare at NVIDIA
Moon Surgical today announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use in various surgical interventions.
The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments.
Moon Surgical has now integrated Holoscan into its commercial Maestro System to enable its first computer vision-based capability, the ScoPilot™.
"This proof-of-concept showing an AI application running on NVIDIA Holoscan in real-time during Maestro surgery validates the principle behind our platform."

Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated

Retrieved on:

Tuesday, March 19, 2024

Growth, Surgeon, System, Patient, SAN, Hospital, Health care, Laparoscopy, Instrument, Moon, Nvidia, Sofinnova, Nursing, Artificial intelligence, Medtech

Moon Surgical today announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use in various surgical interventions.

Key Points:

Moon Surgical today announced that over 200 patients have been successfully treated with its Maestro System, powered by NVIDIA Holoscan, which delivers surgeon autonomy in its first commercial use in various surgical interventions.
The Maestro System is used in laparoscopy, where surgeons operate through small incisions with an internal camera and instruments.
Moon Surgical has now integrated Holoscan into its commercial Maestro System to enable its first computer vision-based capability, the ScoPilot™.
"This proof-of-concept showing an AI application running on NVIDIA Holoscan in real-time during Maestro surgery validates the principle behind our platform."